NASONEX 50 micrograms/dose, suspension for nasal spray, vial of 140 doses

 

Active ingredient

Mometasone furoate

 

NASONEX is usually prescribed for:

Seasonal or perennial allergic rhinitis

Nasosinus polyposis

NASONEX- Indications

NASONEX nasal spray is indicated in adults and children from 3 years of age for the symptomatic treatment of seasonal allergic rhinitis or perennial rhinitis.

NASONEX Nasal Spray is indicated for the treatment of nasal polyposis in adults over 18 years of age.